Compare BLCO & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | EPRT |
|---|---|---|
| Founded | 1853 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.0B |
| IPO Year | 2022 | 2018 |
| Metric | BLCO | EPRT |
|---|---|---|
| Price | $16.97 | $30.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $17.31 | ★ $35.27 |
| AVG Volume (30 Days) | 338.6K | ★ 1.7M |
| Earning Date | 02-18-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 4.09% |
| EPS Growth | N/A | ★ 8.17 |
| EPS | N/A | ★ 1.24 |
| Revenue | ★ $4,976,000,000.00 | $531,061,000.00 |
| Revenue This Year | $8.06 | $24.48 |
| Revenue Next Year | $5.79 | $17.26 |
| P/E Ratio | ★ N/A | $24.38 |
| Revenue Growth | 6.23 | ★ 23.93 |
| 52 Week Low | $10.45 | $27.44 |
| 52 Week High | $18.14 | $33.35 |
| Indicator | BLCO | EPRT |
|---|---|---|
| Relative Strength Index (RSI) | 48.89 | 47.37 |
| Support Level | $16.85 | $30.26 |
| Resistance Level | $17.54 | $31.20 |
| Average True Range (ATR) | 0.43 | 0.58 |
| MACD | -0.06 | 0.08 |
| Stochastic Oscillator | 46.95 | 46.23 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.